Douros, Antonios
Durand, Madeleine
Doyle, Carla M.
Yoon, Sarah
Reynier, Pauline
Filion, Kristian B. http://orcid.org/0000-0001-6055-0088
Funding for this research was provided by:
Canadian Institutes of Health Research (DSE-146021)
Article History
First Online: 7 June 2019
Compliance with Ethical Standards
:
: Antonios Douros, Madeleine Durand, Carla M. Doyle, Sarah Yoon, Pauline Reynier, and Kristian B. Filion have no conflicts of interest that are directly relevant to the content of this study.
: This research was funded by the Canadian Network for Observational Drug Effects Studies (CNODES), a collaborating center of the Drug Safety and Effectiveness Network (DSEN), funded by the Canadian Institutes of Health Research (grant number DSE-146021). The CNODES Investigators are as follows: Samy Suissa (Principal Investigator); Colin R. Dormuth (British Columbia); Brenda R. Hemmelgarn (Alberta); Gary F. Teare (Saskatchewan); Patricia Caetano and Dan Chateau (Manitoba); David A. Henry and J. Michael Paterson (Ontario); Jacques LeLorier (Québec); Adrian R. Levy (Atlantic [Nova Scotia, Newfoundland and Labrador, New Brunswick, Prince Edward Island]); Pierre Ernst and Kristian B. Filion (United Kingdom Clinical Practice Research Datalink [CPRD]); Robert W. Platt (Methods); and Ingrid S. Sketris (Knowledge Translation).
: This work is the sole product of the authors and has never been submitted for publication or presented in a public setting.